Lv11
16 积分 2025-03-03 加入
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
44分钟前
待确认
Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pathway
2小时前
已完结
Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway
2小时前
已完结
Hypocrellin A against intrahepatic Cholangiocarcinoma via multi-target inhibition of the PI3K-AKT-mTOR, MAPK, and STAT3 signaling pathways
4小时前
已完结
皖公网安备34019202002308
